OncoTrace™ 5000 Liquid Biopsy Platform / OncoTrace™ 5000

Price：￥

A sleek, benchtop genomic sequencer with a screen showing ctDNA analysis results.

Description :

The OncoTrace™ 5000 is a next-generation, high-throughput liquid biopsy platform for the ultra-sensitive detection of circulating tumor DNA (ctDNA). Utilizing our advanced molecular diagnostic and chemical luminescence platforms, it enables early cancer detection, minimal residual disease (MRD) monitoring, and therapy selection, all from a simple blood draw.

Key Features:

· 0.01% Variant Allele Frequency (VAF) Sensitivity for detecting minimal residual disease.

· 150-Gene Pan-Cancer Panel covering major solid tumors.

· 48-Hour Turnaround Time from sample to comprehensive report.

Online inquiry